PanGen Biotech Inc. (KOSDAQ: 222110)
South Korea
· Delayed Price · Currency is KRW 4,870.00
-220.00 (-4.32%)
Jan 22, 2025, 3:00 PM KST
PanGen Biotech Revenue
PanGen Biotech had revenue of 4.60B KRW in the quarter ending September 30, 2024, with 129.39% growth. This brings the company's revenue in the last twelve months to 13.72B, up 179.56% year-over-year. In the year 2023, PanGen Biotech had annual revenue of 7.32B with 12.53% growth.
Revenue (ttm)
13.72B
Revenue Growth
+179.56%
P/S Ratio
4.10
Revenue / Employee
n/a
Employees
n/a
Market Cap
65.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7.32B | 814.47M | 12.53% |
| Dec 31, 2022 | 6.50B | -1.43B | -18.08% |
| Dec 31, 2021 | 7.94B | 1.74B | 28.18% |
| Dec 31, 2020 | 6.19B | 3.31B | 114.87% |
| Dec 31, 2019 | 2.88B | -2.80B | -49.27% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 292.86T |
| SK hynix | 57.73T |
| LG Energy Solution | 27.17T |
| Samsung Biologics Co.,Ltd. | 4,364.39B |
| Hyundai Motor Company | 170.28T |
| Kia Corporation | 104.63T |
| Celltrion | 2,876.25B |
| KB Financial Group | 14.11T |